Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

Figure 1

Functional transfer constant map of HCC during sunitinib therapy. Coronal enhanced MR T1-weighted images (A, B) and functional transfer constant (Ktrans) maps from MR perfusion (C, D) at baseline and after 2-week of sunitinib therapy in a 47-year-old man with HCC (arrows). After two weeks of treatment with sunitinib, HCC showed a 96% drop of Ktrans, which presented a conspicuity of permeability change.

Back to article page